第六届疫苗中国发展国际峰会是2016年中国最大的疫苗行业国际峰会，几乎涵盖了整个疫苗产业链上的所有参与者。在此，我们将邀请超过300位国内外人用疫苗及兽用疫苗领域的顶级专家、学者、企业高管等行业领袖共同探讨人用及兽用疫苗行业的最新发展趋势，研发热点，合作模式，生产技术、市场及商业化策略等热点话题。同时我们将为国内外企业之间、产业界及学术界之间搭建学习、合作、交流的平台，从而推动中国及新兴市场疫苗产业的快速、健康发展。
主办单位：上海士研广告传媒有限公司
支持单位：
台湾生物产业发展协会
台湾生物产业发展协会(Taiwan Bio Industry Organization)成立于1989年，为台湾历史最优久且涵盖最多产业及学术代表的生技专业团体，本会会员包含许多根基稳固的资深厂商、新兴生技公司、学术研究机构及政府单位代表等，本会以联系并结合产业界及各学术部门，共同推动生物科技产业，以发展我国经济及提高全民生活质量为宗旨。
本协会每年除了举办各项研讨会、训练课程及产业交流等活动，其中最主要的就是主办台湾生技月(BioTaiwan)活动—包含生物科技大展、亚洲生技商机高峰论坛、商机媒合会、两岸生医产业合作研讨会等活动，在产官学各方的努力经营之下，本活动已成为亚太地区规模最大、吸引最多国际专业人士参与的生技活动之一。
中国生物技术集团
中国生物技术股份有限公司（中生股份）是中国最大的生物制药企业。研发、生产并销售用于疾病预防、治疗和诊断的一系列生物医药制品。中生股份是中国最大的人用疫苗生产厂家，和中国最大的血液制品生产厂家，供应中国国内41个疫苗品种中的35种。作为中国生物制药行业的领先企业，中生股份成功研发上市了一系列行业领先生物医药产品。
国际疫苗学会
International Society for Vaccines is an organization that engages, supports and sustains the professional goals of a diverse membership in all areas relevant to vaccines. With the successful conclusion of the 2013 Vaccine and ISV Annual Congress and ISV General Meeting, a new set of elected officials to the Executive Board will guide the Society for the next two years. Goals are focused on expanding the membership database and the enhanced attendance at the Annual Congresses. In addition, an out research initiative has begun to partner with organizations to promote ISV activities, such as VacChina 2014.
国际疫苗研究所
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Its mission is to discover, develop, and deliver safe, effective and affordable vaccines for developing nations. Established in 1997 at the initiative of the United Nations Development Program (UNDP), IVI operates as an independent nonprofit organization under a treaty signed by 35 countries and the World Health Organization (WHO). The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines primarily against enteric and diarrheal infections, Japanese encephalitis, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea, its host country. For more information, please visit www.ivi.int.